Professional Documents
Culture Documents
Priority Approval-Registration of Drugs During The COVID-19 Pandemic
Priority Approval-Registration of Drugs During The COVID-19 Pandemic
CIRCULAR
Subject: PRIORITY APPROVAL/ REGISTRATION OF DRUGS DURING THE
COVID-19 PANDEMIC.
April, 2020 on the subject captioned above and to inform that the last date for
submission of applications has been extended till 05 th May, 2020. However, other terms
/j/Y;tt2�):) -- ,..
!.
_
T
(AI J LLJ\)1)
Adtiitional Director (PE&R)
Distribution:-
1. Chairman, Pakistan Pharmaceutical Manufacturers Association, Islamabad.
11. Executive Director, Pharma Bureau, Karachi.
m. Executive Director/Chairman, Pakistan Chemist & Druggists Association
(PCDA), Karachi.
/v· Additional Director, MIS Division, for uploading on DRAP's website.